Skip to content

Importance and impact of CoQ-10 on oocyte formation in infertile females

Role of Coenzyme Q10 on oocyte quality in Poseidon Groups-a multicentred parallel group open labelled randomized controlled trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/049193
Enrollment
570
Registered
2023-01-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O090- Supervision of pregnancy with history of infertility

Interventions

Intervention1: CoenzymeQ10 (Multinutrient): The multinutrient CoenzymeQ10 with 300 mg is given 2 times daily for 3 months Control Intervention1: Placebo: Placebo of same color and odour will be given

Sponsors

Indira IVF Hospital Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 25–45 years, (both inclusive) 2. Body mass index (BMI) 18.5 to 25 kg/m2 3. AMH

Exclusion criteria

Exclusion criteria: 1. Any existing uncontrolled medical illness such as Diabetes, Hypertension, Thyroid disorder. 2. History of smoking within 3 months. 3. Use of any androgen preparations like DHEA within 3 months of stimulation. 4. Congenital uterine anomaly. 5. Ovarian cyst. 6. Pelvic or systemic inflammatory disease. 7. Involved in intensive weight loosing or athletic activities other than usual activities.

Design outcomes

Primary

MeasureTime frame
M2 RateTimepoint: At the time of pick up

Secondary

MeasureTime frame
Aneuploidy rate Timepoint: 5 days after OPU;Clinical Pregnancy Timepoint: 4 weeks following ET;Follicle Oocyte IndexTimepoint: On day of OPU;Implantation Rate Timepoint: 4 weeks following ET;Live BirthTimepoint: 36 weeks after embryo transfer;Ongoing Pregnancy Timepoint: 12 weeks following ET;Oocyte Retrieval rate Timepoint: On day of OPU

Countries

India

Contacts

Public ContactDr Nihar Bhoi

Indira IVF Hospital Pvt Ltd

drnihar.bhoi@indiraivf.in07205783512

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026